Live Breaking News & Updates on Consortium For Clinical Investigation Of Neurologic Channelopathies

Stay updated with breaking news from Consortium for clinical investigation of neurologic channelopathies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lupin Ltd: Lupin's Namuscla (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)

FOR UK MEDICAL AND TRADE MEDIA ONLY Lupin's Namuscla (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) Slough ....

United Kingdom , South Africa , Ben Ellis , Asia Pacific , Sukaina Virji , Consortium For Clinical Investigation Of Neurologic Channelopathies , National Institute For Health , Lupin Healthcare United Kingdom , Biotechnology Pharmaceuticals , European Union , Consilium Strategic Communications , National Institute , Care Excellence , Final Appraisal Determination , General Manager , Lupin Healthcare United , Non Dystrophic Myotonias , Latin America , Great Place , Appraisal Document , Raja Rayan , Clinical Investigation , Neurol Neurosurg , Healthcare United Kingdom Limited , Product Characteristics ,

Investegate |Lupin Ltd Announcements | Lupin Ltd: Lupin's Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)

Investegate announcements from Lupin Ltd, Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) ....

United Kingdom , South Africa , Ben Ellis , Asia Pacific , Sukaina Virji , Consortium For Clinical Investigation Of Neurologic Channelopathies , National Institute For Health , Lupin Healthcare United Kingdom , Biotechnology Pharmaceuticals , European Union , Consilium Strategic Communications , National Institute , Care Excellence , Final Appraisal Determination , General Manager , Lupin Healthcare United , Non Dystrophic Myotonias , Latin America , Great Place , Appraisal Document , Raja Rayan , Clinical Investigation , Healthcare United Kingdom Limited , Investegate Announcements , Investegate Company Announcements , Lupin Ltd ,